1Yoo LI, Chung DC, Yuan J. LKB1--a master tumour suppressor of the small intestine and beyond. Nat Rev Cancer. 2002 Jul;2(7):529-35. Review. No abstract available.
PMID: 12094239 [PubMed - indexed for MEDLINE]
2Collins SP, Reoma JL, Gamm DM, Uhler MD. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem J. 2000 Feb 1;345 Pt 3:673-80.
PMID: 10642527 [PubMed - indexed for MEDLINE]
3Boudeau J, Kieloch A, Alessi DR, Stella A, Guanti G, Resta N. Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients. Hum Mutat. 2003 Feb;21(2):172.
PMID: 12552571 [PubMed - indexed for MEDLINE]
4McGarrity TJ, Peiffer LP, Amos CI, Frazier ML, Ward MG, Howett MK. Overexpression of cyclooxygenase 2 in hamartomatous polyps of Peutz-Jeghers syndrome. Am J Gastroenterol 2003 Mar;98(3):671-8
PMID: 12650805
5Rossi DJ, Ylikorkala A, Korsisaari N, Salovaara R, Luukko K, Launonen V, Henkemeyer M, Ristimaki A, Aaltonen LA, Makela TP. Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12327-32.
PMID: 12218179 [PubMed - indexed for MEDLINE]
Full text Available for free at http://www.ncbi.nlm.nih.gov/PubMed/
6Suphat Subongkot, Pharm.D., David Frame, Pharm.D., William Leslie, M.D., Deborah Drajer, Pharm.D. Selective Cyclooxygenase-2 Inhibition: A Target in Cancer Prevention and Treatment Pharmacotherapy
http://www.medscape.com/viewarticle/448279
© 2004 by Stephanie Sugars, all rights reserved, used by permission. No part of this article may be reproduced in any form without written permission from the author.
Contact Stephanie Sugars at PJ4Steph@aol.com
Update: 19.May'04